David A Rodeberg
Affiliation: East Carolina University
- Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of PDavid A Rodeberg
Department of Pediatric Surgery, Children s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
Int J Cancer 128:1232-9. 2011..In conclusion, the majority of BP RMS patients had localized ERMS with a resultant good prognosis using current treatment algorithms. There were differences in FFS between treatment protocols but this did not result in an altered OS...
- Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology GroupDavid A Rodeberg
Children s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
J Clin Oncol 29:1304-11. 2011..Regional lymph node disease (RLND) is a component of the risk-based treatment stratification in rhabdomyosarcoma (RMS). The purpose of this study was to determine the contribution of RLND to prognosis for patients with RMS...
- Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology groupDavid A Rodeberg
University of Pittsburgh School of Medicine, Department of Pediatric Surgery, Children s Hospital of Pittsburgh, Pittsburgh, PA 15213 2585, USA
J Clin Oncol 27:3705-11. 2009..Some patients with rhabdomyosarcoma (RMS) achieve less than a complete response (CR) despite receiving all planned therapy. We assessed the impact of best response at the completion of all therapy on patient outcome...